These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23319024)

  • 21. Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure.
    Merkesdal S; Kirchhoff T; Wolka D; Ladinek G; Kielhorn A; Rubbert-Roth A
    Eur J Health Econ; 2010 Feb; 11(1):95-104. PubMed ID: 19967426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L12. Rheumatoid arthritis vasculitis.
    Puéchal X
    Presse Med; 2013 Apr; 42(4 Pt 2):527-30. PubMed ID: 23481361
    [No Abstract]   [Full Text] [Related]  

  • 23. BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.
    Bukhari M; Abernethy R; Deighton C; Ding T; Hyrich K; Lunt M; Luqmani R; Kiely P; Bosworth A; Ledingham J; Ostör A; Gadsby K; McKenna F; Finney D; Dixey J;
    Rheumatology (Oxford); 2011 Dec; 50(12):2311-3. PubMed ID: 21546351
    [No Abstract]   [Full Text] [Related]  

  • 24. B-cell therapies in established rheumatoid arthritis.
    Leandro MJ; Becerra-Fernandez E
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):535-48. PubMed ID: 22137923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synovium.
    Gutierrez-Roelens I; Galant C; Theate I; Lories RJ; Durez P; Nzeusseu-Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
    Arthritis Rheum; 2011 May; 63(5):1246-54. PubMed ID: 21337318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.
    Otremba MD; Adam SI; Price CC; Hohuan D; Kveton JF
    Am J Otolaryngol; 2012; 33(5):619-22. PubMed ID: 22361345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis.
    Salliot C; Finckh A; Katchamart W; Lu Y; Sun Y; Bombardier C; Keystone E
    Ann Rheum Dis; 2011 Feb; 70(2):266-71. PubMed ID: 21097801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic orbital inflammation successfully treated using rituximab in a patient with rheumatoid arthritis.
    Ibrahim I; Barton A; Ibrahim A; Ho P
    J Rheumatol; 2012 Jul; 39(7):1485-6. PubMed ID: 22753803
    [No Abstract]   [Full Text] [Related]  

  • 29. Colitis associated with active systemic lupus erythematosus successfully treated with rituximab.
    Tayal V; Chiu YH; George E; Mane S
    J Clin Rheumatol; 2011 Mar; 17(2):79-82. PubMed ID: 21325960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experience.
    Jois RN; Masding A; Somerville M; Gaffney K; Scott DG
    Rheumatology (Oxford); 2007 Jun; 46(6):980-2. PubMed ID: 17384180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Safety of rituximab in patients with rheumatoid arthritis].
    Morović-Vergles J
    Reumatizam; 2010; 57(2):158-60. PubMed ID: 21875022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory urticarial vasculitis as a complication of ulcerative colitis successfully treated with rituximab.
    Swaminath A; Magro CM; Dwyer E
    J Clin Rheumatol; 2011 Aug; 17(5):281-3. PubMed ID: 21778903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.
    Tak PP; Rigby WF; Rubbert-Roth A; Peterfy CG; van Vollenhoven RF; Stohl W; Hessey E; Chen A; Tyrrell H; Shaw TM;
    Ann Rheum Dis; 2011 Jan; 70(1):39-46. PubMed ID: 20937671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab-it was the best of times, it was the worst of times.
    Isenberg DA
    Autoimmun Rev; 2012 Sep; 11(11):790-1. PubMed ID: 22349619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis.
    Hellmann M; Jung N; Owczarczyk K; Hallek M; Rubbert A
    Rheumatology (Oxford); 2008 Jun; 47(6):929-30. PubMed ID: 18411212
    [No Abstract]   [Full Text] [Related]  

  • 36. Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab.
    Hogan VE; Holweg CT; Choy DF; Kummerfeld SK; Hackney JA; Teng YK; Townsend MJ; van Laar JM
    Ann Rheum Dis; 2012 Nov; 71(11):1888-94. PubMed ID: 22736099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab - shadow, illusion or light?
    van Vollenhoven RF
    Autoimmun Rev; 2012 Jun; 11(8):563-7. PubMed ID: 22036829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Successful treatment with rituximab in a refractory Stiff-person syndrome].
    Sevy A; Franques J; Chiche L; Pouget J; Attarian S
    Rev Neurol (Paris); 2012 Apr; 168(4):375-8. PubMed ID: 22340864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Targeting CD20 in rheumatoid arthritis].
    Saito K; Tanaka Y
    Nihon Rinsho; 2007 Jul; 65(7):1243-9. PubMed ID: 17642239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking, rheumatoid factor status and responses to rituximab.
    Khan A; Scott DL; Batley M
    Ann Rheum Dis; 2012 Sep; 71(9):1587-8. PubMed ID: 22532635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.